(Q44897910)

English

Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile (English)

1 reference

Europe PubMed Central

7 December 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Jyoti Kalbag

1

1 reference

Europe PubMed Central

7 December 2017

Cheryl Elder

2

1 reference

Europe PubMed Central

7 December 2017

Graham Scott

3

1 reference

Europe PubMed Central

7 December 2017

Yibin Wang

4

1 reference

Europe PubMed Central

7 December 2017

Slavica Milosavljev

5

1 reference

Europe PubMed Central

7 December 2017

Philipp Leese

6

1 reference

Europe PubMed Central

7 December 2017

Jacque Caldwell

7

1 reference

Europe PubMed Central

7 December 2017

Christiane Rordorf

8

1 reference

Europe PubMed Central

7 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

7 December 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

7 December 2017

44

1 reference

Europe PubMed Central

7 December 2017

6

1 reference

Europe PubMed Central

7 December 2017

646-654

1 reference

Europe PubMed Central

7 December 2017

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Clinical pharmacokinetics of oral contraceptive steroids

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Metabolism of 17 alpha-ethynylestradiol in humans

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Oral contraceptive steroids —pharmacological issues of interest to the prescribing physician

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Gastrointestinal metabolism of contraceptive steroids

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Oral contraceptives. Are drug interactions of clinical significance?

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

The effect of rifampicin on norethisterone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Rifampin and rifabutin drug interactions: an update

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Possible interaction between oxcarbazepine and an oral contraceptive

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Changes in plasma protein binding have little clinical relevance

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.

1 reference

https://api.crossref.org/works/10.1177%2F0091270004265363

21 January 2018

Identifiers

10.1177/0091270004265363

1 reference

Europe PubMed Central

7 December 2017

release_t343t2bzujbb5iskwfincikzje

1 reference

https://api.fatcat.wiki/v0/release/t343t2bzujbb5iskwfincikzje

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44897910&oldid=2144493662"